Vise Technologies Inc. Takes Position in Encompass Health Corporation $EHC

Vise Technologies Inc. bought a new position in Encompass Health Corporation (NYSE:EHC) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 5,573 shares of the company’s stock, valued at approximately $563,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new stake in Encompass Health during the 2nd quarter valued at $1,059,762,000. Northwestern Mutual Wealth Management Co. increased its position in shares of Encompass Health by 3,059,159.7% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,793,482 shares of the company’s stock valued at $402,640,000 after acquiring an additional 3,793,358 shares during the period. Norges Bank bought a new position in shares of Encompass Health during the fourth quarter valued at about $133,221,000. Price T Rowe Associates Inc. MD raised its stake in shares of Encompass Health by 24.6% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 4,805,413 shares of the company’s stock valued at $510,047,000 after acquiring an additional 948,202 shares during the last quarter. Finally, Bank of New York Mellon Corp purchased a new stake in shares of Encompass Health during the second quarter worth about $81,676,000. 97.25% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts recently issued reports on EHC shares. Wall Street Zen raised Encompass Health from a “hold” rating to a “buy” rating in a research note on Sunday, August 16th. Leerink Partners set a $152.00 price objective on Encompass Health in a report on Friday, May 22nd. Barclays lifted their price objective on Encompass Health from $140.00 to $144.00 and gave the stock an “overweight” rating in a research report on Thursday, August 6th. Truist Financial boosted their target price on Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a research note on Friday, August 7th. Finally, UBS Group upped their target price on Encompass Health from $150.00 to $155.00 and gave the company a “buy” rating in a report on Friday, August 7th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, Encompass Health has a consensus rating of “Buy” and an average price target of $148.71.

Encompass Health Trading Up 0.5%

Shares of EHC opened at $120.94 on Tuesday. Encompass Health Corporation has a 1-year low of $92.77 and a 1-year high of $127.99. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.76. The firm’s 50-day moving average price is $111.44 and its 200-day moving average price is $106.66. The firm has a market capitalization of $11.93 billion, a price-to-earnings ratio of 19.70, a PEG ratio of 2.43 and a beta of 0.72.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Wednesday, August 5th. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.48 by $0.07. Encompass Health had a net margin of 10.01% and a return on equity of 18.08%. The company had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.57 billion. During the same period in the prior year, the firm earned $1.40 earnings per share. Encompass Health’s revenue was up 9.6% on a year-over-year basis. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. Sell-side analysts anticipate that Encompass Health Corporation will post 6.09 EPS for the current year.

Encompass Health Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be paid a $0.21 dividend. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Thursday, October 1st. This is a boost from Encompass Health’s previous quarterly dividend of $0.19. Encompass Health’s dividend payout ratio (DPR) is 12.38%.

Insider Activity at Encompass Health

In other Encompass Health news, EVP John Patrick Darby sold 8,906 shares of the firm’s stock in a transaction on Monday, August 10th. The stock was sold at an average price of $125.95, for a total transaction of $1,121,710.70. Following the completion of the transaction, the executive vice president owned 75,041 shares of the company’s stock, valued at approximately $9,451,413.95. This trade represents a 10.61% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Mark J. Tarr sold 173,148 shares of the company’s stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $125.47, for a total transaction of $21,724,879.56. Following the completion of the sale, the chief executive officer directly owned 267,814 shares in the company, valued at $33,602,622.58. This represents a 39.27% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 1.80% of the company’s stock.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.